An unpublished Nordic study prompted Sweden and Denmark on Wednesday to announce a pause on the use of the Moderna vaccine in younger age groups.
The study, which hasn’t been reviewed yet by the European Medicines Agency, raised concern over the risk of myocarditis and pericarditis in this demographic.
JUST IN – Sweden halts vaccinations against #COVID19 with Moderna’s Spikevax for those born 1991 or later, citing side effects including heart muscle inflammation, according to public health authorities (Expressen)
— Disclose.tv (@disclosetv) October 6, 2021
While the risk is small, “the connection is especially clear when it comes to Moderna’s vaccine Spikevax, especially after the second dose,” the Swedish health agency said in a statement, Reuters reports.
According to the agency, the risk was also more prevalent among young men and boys.
Denmark made the same “precautionary” call, though the Pfizer/BioNTech vaccine was already the primary option for those aged 12-17 in the country. (Read more from “Two Countries Just Halted Use of the Moderna Vaccine for Certain Groups” HERE)